Lv650
3000 积分 2024-04-28 加入
Imbuing peptide libraries with drug-likeness
10天前
已完结
Development of Orally Bioavailable Peptides Targeting an Intracellular Protein: From a Hit to a Clinical KRAS Inhibitor
17天前
已完结
The current state of the art and future trends in RAS-targeted cancer therapies
20天前
已完结
Site-Selective Anti-PD-L1 Antibody–MMAE Conjugate for Enhanced NSCLC Therapy
30天前
已关闭
Discovery of an Orally Bioavailable and Selective PKMYT1 Inhibitor, RP-6306
1个月前
已完结
What’s next for the synthetic lethality drug discovery engine?
1个月前
已完结
Total Synthesis of Enlicitide Decanoate
2个月前
已完结
MYC in cancer: from undruggable target to clinical trials
3个月前
已完结
Redox-neutral organocatalytic Mitsunobu reactions
3个月前
已完结
Discovery of New Targets to Control Metastasis in Pancreatic Cancer by Single-cell Transcriptomics Analysis of Circulating Tumor Cells
4个月前
已完结
皖公网安备34019202002308
